|
1
|
Lee YJ, Lee YM, Lee CK, Jung JK, Han SB
and Hong JT: Therapeutic applications of compounds in the Magnolia
family. Pharmacol Ther. 130:157–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaushik G, Kwatra D, Subramaniam D, Jensen
RA, Anant S and Mammen JM: Honokiol affects melanoma cell growth by
targeting the AMP-activated protein kinase signaling pathway. Am J
Surg. 208:995–1002; discussion 1001–1002. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McKeown BT and Hurta RA: Magnolol affects
expression of IGF-1 and associated binding proteins in human
prostate cancer cells in vitro. Anticancer Res. 34:6333–6338.
2014.PubMed/NCBI
|
|
4
|
Zhou Y, Bi Y, Yang C, Yang J, Jiang Y,
Meng F, Yu B, Khan M, Ma T and Yang H: Magnolol induces apoptosis
in MCF-7 human breast cancer cells through G2/M phase arrest and
caspase-independent pathway. Pharmazie. 68:755–762. 2013.PubMed/NCBI
|
|
5
|
Tsai JR, Chong IW, Chen YH, Hwang JJ, Yin
WH, Chen HL, Chou SH, Chiu CC and Liu PL: Magnolol induces
apoptosis via caspase-independent pathways in non-small cell lung
cancer cells. Arch Pharm Res. 37:548–557. 2014. View Article : Google Scholar
|
|
6
|
Lai YJ, Lin CI, Wang CL and Chao JI:
Expression of survivin and p53 modulates honokiol-induced apoptosis
in colorectal cancer cells. J Cell Biochem. 115:1888–1899.
2014.PubMed/NCBI
|
|
7
|
Liang WZ, Chou CT, Chang HT, Cheng JS, Kuo
DH, Ko KC, Chiang NN, Wu RF, Shieh P and Jan CR: The mechanism of
honokiol-induced intracellular Ca(2+) rises and apoptosis in human
glioblastoma cells. Chem Biol Interact. 221:13–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Monteiro J and Fodde R: Cancer stemness
and metastasis: Therapeutic consequences and perspectives. Eur J
Cancer. 46:1198–1203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deep G and Agarwal R: Antimetastatic
efficacy of silibinin: Molecular mechanisms and therapeutic
potential against cancer. Cancer Metastasis Rev. 29:447–463. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ljungberg B, Hanbury DC, Kuczyk MA,
Merseburger AS, Mulders PF, Patard JJ and Sinescu IC; European
Association of Urology Guideline Group for renal cell carcinoma.
Renal cell carcinoma guideline. Eur Urol. 51:1502–1510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ellerbroek SM, Wennerberg K and Burridge
K: Serine phosphorylation negatively regulates RhoA in vivo. J Biol
Chem. 278:19023–19031. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pellegrin S and Mellor H: Actin stress
fibres. J Cell Sci. 120:3491–3499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shoji S, Tang XY, Umemura S, Itoh J,
Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, et
al: Metastin inhibits migration and invasion of renal cell
carcinoma with overexpression of metastin receptor. Eur Urol.
55:441–449. 2009. View Article : Google Scholar
|
|
17
|
Pu YS, Wang CW, Liu GY, Kuo YZ, Huang CY,
Kang WY, Shun CT, Lin CC, Wu WJ and Hour TC: Down-regulated
expression of RhoA in human conventional renal cell carcinoma.
Anticancer Res. 28(4B): 2039–2043. 2008.PubMed/NCBI
|
|
18
|
Cheng S, Castillo V, Eliaz I and Sliva D:
Honokiol suppresses metastasis of renal cell carcinoma by targeting
KISS1/KISS1R signaling. Int J Oncol. 46:2293–2298. 2015.PubMed/NCBI
|
|
19
|
Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Modulation of human renal cell carcinoma
786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Med Oncol. 23:245–250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng
Q, Wang F and Yuan J: LIM and SH3 domain protein 1 (LASP-1)
overexpression was associated with aggressive phenotype and poor
prognosis in clear cell renal cell cancer. PLoS One. 9:e1005572014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang J, Slivova V, Harvey K,
Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of
breast cancer cells through the inhibition of Akt/NF-kappaB
signaling. Nutr Cancer. 49:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sliva D, Jedinak A, Kawasaki J, Harvey K
and Slivova V: Phellinus linteus suppresses growth, angiogenesis
and invasive behaviour of breast cancer cells through the
inhibition of AKT signalling. Br J Cancer. 98:1348–1356. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lloyd FP Jr, Slivova V, Valachovicova T
and Sliva D: Aspirin inhibits highly invasive prostate cancer
cells. Int J Oncol. 23:1277–1283. 2003.PubMed/NCBI
|
|
24
|
Kim DW, Ko SM, Jeon YJ, Noh YW, Choi NJ,
Cho SD, Moon HS, Cho YS, Shin JC, Park SM, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013.PubMed/NCBI
|
|
25
|
Joo YN, Eun SY, Park SW, Lee JH, Chang KC
and Kim HJ: Honokiol inhibits U87MG human glioblastoma cell
invasion through endothelial cells by regulating membrane
permeability and the epithelial-mesenchymal transition. Int J
Oncol. 44:187–194. 2014.
|
|
26
|
Tian W, Deng Y, Li L, He H, Sun J and Xu
D: Honokiol synergizes chemotherapy drugs in multidrug resistant
breast cancer cells via enhanced apoptosis and additional
programmed necrotic death. Int J Oncol. 42:721–732. 2013.
|
|
27
|
Hahm ER, Sakao K and Singh SV: Honokiol
activates reactive oxygen species-mediated cytoprotective autophagy
in human prostate cancer cells. Prostate. 74:1209–1221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chilampalli C, Zhang X, Kaushik RS, Young
A, Zeman D, Hildreth MB, Fahmy H and Dwivedi C: Chemopreventive
effects of combination of honokiol and magnolol with α-santalol on
skin cancer developments. Drug Discov Ther. 7:109–115.
2013.PubMed/NCBI
|
|
29
|
Kawauchi T: Cell adhesion and its
endocytic regulation in cell migration during neural development
and cancer metastasis. Int J Mol Sci. 13:4564–4590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ridley AJ: Rho GTPases and cell migration.
J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI
|
|
31
|
Katoh K, Kano Y, Amano M, Kaibuchi K and
Fujiwara K: Stress fiber organization regulated by MLCK and
Rho-kinase in cultured human fibroblasts. Am J Physiol Cell
Physiol. 280:C1669–C1679. 2001.PubMed/NCBI
|
|
32
|
Navenot JM, Fujii N and Peiper SC:
Activation of Rho and Rho-associated kinase by GPR54 and KiSS1
metastasis suppressor gene product induces changes of cell
morphology and contributes to apoptosis. Mol Pharmacol.
75:1300–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen S, Wang J, Gou WF, Xiu YL, Zheng HC,
Zong ZH, Takano Y and Zhao Y: The involvement of RhoA and Wnt-5a in
the tumorigenesis and progression of ovarian epithelial carcinoma.
Int J Mol Sci. 14:24187–24199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Horiuchi A, Imai T, Wang C, Ohira S, Feng
Y, Nikaido T and Konishi I: Up-regulation of small GTPases, RhoA
and RhoC, is associated with tumor progression in ovarian
carcinoma. Lab Invest. 83:861–870. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kamai T, Yamanishi T, Shirataki H, Takagi
K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1, and
Cdc42 GTPases is associated with progression in testicular cancer.
Clin Cancer Res. 10:4799–4805. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Chen D and Liu G: Overexpression of
RhoA promotes the proliferation and migration of cervical cancer
cells. Biosci Biotechnol Biochem. 78:1895–1901. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patel M, Kawano T, Suzuki N, Hamakubo T,
Karginov AV and Kozasa T: Gα13/PDZ-RhoGEF/RhoA signaling is
essential for gastrin-releasing peptide receptor-mediated colon
cancer cell migration. Mol Pharmacol. 86:252–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin L, Yang XM, Li J, Zhang YL, Qin W and
Zhang ZG: Microfilament regulatory protein MENA increases activity
of RhoA and promotes metastasis of hepatocellular carcinoma. Exp
Cell Res. 327:113–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takeda S, Okajima S, Miyoshi H, Yoshida K,
Okamoto Y, Okada T, Amamoto T, Watanabe K, Omiecinski CJ and
Aramaki H: Cannabidiolic acid, a major cannabinoid in fiber-type
cannabis, is an inhibitor of MDA-MB-231 breast cancer cell
migration. Toxicol Lett. 214:314–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen X, Corbin JM, Tipton GJ, Yang LV,
Asch AS and Ruiz-Echevarría MJ: The TMEFF2 tumor suppressor
modulates integrin expression, RhoA activation and migration of
prostate cancer cells. Biochim Biophys Acta. 1843:1216–1224. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ridley AJ, Schwartz MA, Burridge K, Firtel
RA, Ginsberg MH, Borisy G, Parsons JT and Horwitz AR: Cell
migration: Integrating signals from front to back. Science.
302:1704–1709. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang X, Li C, Gao H, Nabeka H, Shimokawa
T, Wakisaka H, Matsuda S and Kobayashi N: Rho kinase inhibitors
stimulate the migration of human cultured osteoblastic cells by
regulating actomyosin activity. Cell Mol Biol Lett. 16:279–295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tsuji T, Ishizaki T, Okamoto M, Higashida
C, Kimura K, Furuyashiki T, Arakawa Y, Birge RB, Nakamoto T, Hirai
H, et al: ROCK and mDia1 antagonize in Rho-dependent Rac activation
in Swiss 3T3 fibroblasts. J Cell Biol. 157:819–830. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Toda M, Dawson M, Nakamura T, Munro PM,
Richardson RM, Bailly M and Ono SJ: Impact of engagement of
FcepsilonRI and CC chemokine receptor 1 on mast cell activation and
motility. J Biol Chem. 279:48443–48448. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Aspenström P, Fransson A and Saras J: Rho
GTPases have diverse effects on the organization of the actin
filament system. Biochem J. 377:327–337. 2004. View Article : Google Scholar
|
|
46
|
Lepley D, Paik JH, Hla T and Ferrer F: The
G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to
inhibit tumor cell migration. Cancer Res. 65:3788–3795. 2005.
View Article : Google Scholar : PubMed/NCBI
|
